Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6

Apremilast is a phosphodiesterase 4 (PDE4) inhibitor used in the treatment of psoriasis and several other inflammatory diseases. Interest has been expressed in seeking out therapies that address both psoriasis and atherosclerosis. In the present study, we explored the effects of apremilast in human...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Yang, Guang, Zhang, Qian, Liang, Xiao, Liu, Yang, Gao, Meng, Guo, Yutao, Chen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732304/
https://www.ncbi.nlm.nih.gov/pubmed/33052879
http://dx.doi.org/10.18632/aging.103665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732304/
https://www.ncbi.nlm.nih.gov/pubmed/33052879
http://dx.doi.org/10.18632/aging.103665

Ejemplares similares